Dept. Orthopaedics, SUNY@Stony Brook
Stony Brook, New York, 11794, United States
NCT Number: NCT00261209
The purpose of this study is to dissolve flexor tendon adhesions associated with failed tendon repair surgery.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 1 / Phase 2
Stony Brook, New York, 11794, United States
In an open label study, collagenase injection therapy was investigated in 3 subjects for it's ability to lyse flexor tendon adhesions in zone II of the hand.
Results indicate that two of three subjects had improved range of finger motion at the PIP and DIP joints. This may obviate the need for patients to have tenolysis hand surgery to correct the finger flexion contracture of the PIP and DIP joints. Detailed controlled studies remain to be done.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Collagenase injection into adhesion restricting tendon gliding
Other names: Collagenase Clostridium Histolyticum
injection of collagenase into adhesion restricting tendon gliding
Other names: Collagenase Clostridium Histolyticum
Time frame: 6 months
Time frame: 6 months
Stony Brook University
Other
Study of Collagenase Injection Therapy for Treatment of Zone II Flexor Tendon Adhesions in the Hand
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.